BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos Linked to Bladder Cancer


6/1/2012 6:53:35 AM

San Diego, CA (PRWEB) June 01, 2012 -- The media spotlight is often a double-edged sword. No one knows this better than William Blumenstine and his wife, Kathy Jo Williams. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, on May 14th, 2012, a Minnesota man, William Blumenstine, and his wife Kathy Jo Williams filed a lawsuit in Minnesota District Court (case no. 0:2012cv01162) alleging he suffered bladder cancer after taking Actos. Actos (pioglitazone) is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted as decreasing insulin resistance. Blumenstine claims he began taking Actos from 2004 to 2008 to treat his type 2 diabetes. He was diagnosed with bladder cancer in 2008. Plaintiffs are seeking compensatory damages for the injuries.

On April 9th 2012, US District Judge Rebecca Doherty, overseeing the Actos Multidistrict Litigation (In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana) signed a Direct Filing Order making it easier for individual plaintiffs to file lawsuit alleging injury caused by Actos. New victims can file a lawsuit directly in the MDL. Bloomberg reported in March 13th, 2012 that “Takeda, Asia’s biggest drugmaker, may face as many as 10,000 claims that Actos causes bladder cancer after U.S. regulators found last year the drug was linked to the disease.”

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of Actos severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Actos remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In June 2011, the FDA required a new safety label stating that: “The use of Actos for more than one year may increase a person’s chance of bladder cancer”. The French Medicines Agency conducted a study of 155,000 patients over four years which revealed that taking Actos could increase the occurrence of bladder cancer by up to 40%.

AttorneyOne.com has further information on Actos lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Actos at our website. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/5/prweb9555384.htm.



Read at BioSpace.com
Read at EurekAlert!
Read at HealthDay
Read at WebMD
Read at Reuters

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->